Press release
Global Bacterial Conjunctivitis Market Comprehensive Study: Forecasted Market Size And Growth Rate | Pfizer Inc., Johnson & Johnson, F. Hoffman La-Roche Ltd., Merck & Co. Inc., AbbVie Inc., Bayer AG, Sanofi S.A., AstraZeneca PLC, GlaxoSmithKline plc, Eli
Bacterial Conjunctivitis Market Size
The Business Research Company offers in-depth market insights through Bacterial Conjunctivitis Global Market Report 2024, providing businesses with a competitive advantage by thoroughly analyzing the market structure, including estimates for numerous segments and sub-segments.
Market Size And Growth Forecast:
The bacterial conjunctivitis market size has grown strongly in recent years. It will grow from $4.29 billion in 2023 to $4.52 billion in 2024 at a compound annual growth rate (CAGR) of 5.5%. The growth in the historic period can be attributed to increasing incidence of bacterial infections, improved diagnostic capabilities, patient education and awareness programs, stringent regulatory framework, physician training and expertise..
The bacterial conjunctivitis market size is expected to see steady growth in the next few years. It will grow to $5.34 billion in 2028 at a compound annual growth rate (CAGR) of 4.2%. The growth in the forecast period can be attributed to global population growth, rising urbanization and pollution, increased focus on preventive eye care, global health preparedness initiatives, expansion of teleophthalmology services, collaboration in research and development.. Major trends in the forecast period include innovation in drug delivery technologies, customization of treatment regimens, utilization of broad-spectrum antibiotics, introduction of adjunctive therapies, emphasis on patient education and prevention strategies..
Get Free Sample Of This Report-
https://www.thebusinessresearchcompany.com/sample.aspx?id=13383&type=smp
Market Segmentation:
The main types of bacterial conjunctivitis are hyperacute bacterial conjunctivitis, acute bacterial conjunctivitis, and chronic bacterial conjunctivitis. Hyperacute bacterial conjunctivitis is an extremely severe and rapidly progressing form of bacterial conjunctivitis, which is an eye infection characterized by inflammation of the conjunctiva. The various types of drug classes include antibiotics, fluoroquinolones, aminoglycosides, macrolides, antihistamines, corticosteroids, and others, which can be administered through various routes, including oral, topical, and others. These are sold through several distribution channels, such as hospital pharmacies, retail pharmacies, online pharmacies, and others.
Major Driver - Rising Prevalence Of Eye Infections Drives The Bacterial Conjunctivitis Market
The increasing prevalence of eye infections is expected to propel the growth of the bacterial conjunctivitis market going forward. An eye infection is a condition in which the eye is affected by the invasion and multiplication of harmful microorganisms such as bacteria, viruses, fungi, or parasites. It includes conjunctivitis, trachoma, and keratitis. Bacterial conjunctivitis is an eye infection caused by bacteria treated with prescribed medications, self-care techniques, and hygiene measures. For instance, in October 2022, according to the World Health Organization, a Switzerland-based intergovernmental organization, in 2021, approximately 69,000 people underwent surgery for the late and blinding stage of trachoma ( Eye bacterial infection), while 64.6 million people received treatment with antibiotics for trachoma. Furthermore, in October 2022, according to The BrightFocus Foundation, a US-based nonprofit organization, there were currently 80 million glaucoma sufferers globally, and by 2040, it is projected to rise to nearly 111 million. Therefore, the increasing prevalence of eye infections is driving the growth of the bacterial conjunctivitis market.
Competitive Landscape:
Major companies operating in the bacterial conjunctivitis market report are Pfizer Inc., Johnson & Johnson, F. Hoffman La-Roche Ltd., Merck & Co. Inc., AbbVie Inc., Bayer AG, Sanofi S.A., AstraZeneca PLC, GlaxoSmithKline plc, Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., Alcon, Sun Pharmaceutical Industries Ltd., Bausch + Lomb, Dr. Reddy's Laboratories Ltd., Aurobindo Pharma Ltd., Cipla Ltd., Hikma Pharmaceuticals, Santen Pharmaceutical Co. Ltd., Lupin Pharmaceuticals, Glenmark Pharmaceuticals Ltd., Jubilant Life Sciences Ltd., Alembic Pharmaceuticals Ltd., Macleods Pharmaceuticals Ltd., Ocular Therapeutix Inc., Aldeyra Therapeutics, Nicox SA, IACTA Pharmaceuticals Inc., Cellics Therapeutics Inc.
Get Access To The Full Market Report -
https://www.thebusinessresearchcompany.com/report/bacterial-conjunctivitis-global-market-report
Top Trend - Innovative Eye Drops Transforming the Bacterial Conjunctivitis Market
Major companies operating in the bacterial conjunctivitis market are increasing their focus on developing innovative eye drops, such as broad-spectrum eye drops, to maximize their revenues in the market. Broad-spectrum eye drops are medications designed to treat various eye infections, including those caused by various bacteria. These eye drops contain antibiotics that are effective against a broad spectrum of bacteria rather than targeting a specific type. For instance, in June 2023, Harrow Health, a US-based pharmaceutical company, launched Vigamox (moxifloxacin hydrochloride ophthalmic solution) 0.5% in the US. Vigamox is a fluoroquinolone antibiotic eye drop used to treat bacterial conjunctivitis.
The Table Of Content For The Market Report Include:
1. Executive Summary
2. Bacterial Conjunctivitis Market Characteristics
3. Bacterial Conjunctivitis Market Trends And Strategies
4. Bacterial Conjunctivitis Market - Macro Economic Scenario
5. Bacterial Conjunctivitis Market Size And Growth
…..
27. Bacterial Conjunctivitis Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialize in various industries including manufacturing, healthcare, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Bacterial Conjunctivitis Market Comprehensive Study: Forecasted Market Size And Growth Rate | Pfizer Inc., Johnson & Johnson, F. Hoffman La-Roche Ltd., Merck & Co. Inc., AbbVie Inc., Bayer AG, Sanofi S.A., AstraZeneca PLC, GlaxoSmithKline plc, Eli here
News-ID: 3435425 • Views: …
More Releases from The Buisness Research Company
Organic Period Care Products Market Anticipated To Witness Robust Growth, Surpas …
We've updated all our reports with current data on tariff changes, trade developments, and supply chain shifts affecting key industries.
What Is the Current Organic Period Care Products Market Size and Its Estimated Growth Rate?
The size of the market for organic period care products has significantly expanded in recent years, and it's projected to escalate from $2.63 billion in 2024 to $2.83 billion in 2025, with a compound annual growth rate…
Porous Ceramics Market 2024: Trends, Industry Insights, and Growth Drivers
The Business Research Company recently released a comprehensive report on the Global Porous Ceramics Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry.
Ready to Dive into Something Exciting? Get Your Free Exclusive Sample…
AI in Automotive & Transportation Market 2024: Key Trends and Growth Outlook
The Business Research Company recently released a comprehensive report on the Global AI In Automotive And Transportation Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry.
According to The Business Research Company's, The …
Anosmia Global Market 2024 Strategic Outlook Emerging Trends and Market Forecast
The new report published by The Business Research Company, titled Anosmia Global Market Report 2024 - Market Size, Trends, And Global Forecast 2024-2033, delivers an in-depth analysis of the leading size and forecasts, investment opportunities, winning strategies, market drivers and trends, competitive landscape, and evolving market trends.
As per the report, the anosmia market size has grown strongly in recent years. It will grow from $3.24 billion in 2023 to $3.55…
More Releases for Bacterial
Prominent Bacterial Conjunctivitis Market Trend for 2025: Innovative Eye Drops T …
What Are the Projected Growth and Market Size Trends for the Bacterial Conjunctivitis Market?
The bacterial conjunctivitis market has grown steadily, projected to expand from $4.52 billion in 2024 to $4.76 billion in 2025, at a CAGR of 5.3%. Growth factors include rising bacterial infection cases, improved diagnostics, patient education programs, stringent regulatory frameworks, and physician training.
The bacterial conjunctivitis market is projected to grow steadily, reaching $5.54 billion by 2029 at…
Community-Acquired Bacterial Pneumonia Market
DelveInsight's "Community-Acquired Bacterial Pneumonia Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Community-Acquired Bacterial Pneumonia, historical and forecasted epidemiology as well as the Community-Acquired Bacterial Pneumonia market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
The Community-Acquired Bacterial Pneumonia market report provides current treatment practices, emerging drugs, Community-Acquired Bacterial Pneumonia market share of the individual therapies, and current…
Bacterial Conjunctivitis Drugs Market Report 2018: Segmentation by Disease Type …
Global Bacterial Conjunctivitis Drugs market research report provides company profile for Pfizer Inc., Novartis AG, F. Hoffmann-La Roche, Bayer Healthcare, Valeant Pharmaceutical International Inc., Perrigo Company Plc, Akorn Inc., Santen Pharmaceutical Co. Ltd., Allergan Plc. and Others.
This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth…
Bacterial Conjunctivitis Drugs Market: Rising Incidence of Ophthalmic Bacterial …
The U.S. market for bacterial conjunctivitis drugs has been declining sharply over the last few years. Analysts project the trend to continue in the coming years. In 2013, the market’s opportunity was valued at US$473.3 mn, which is likely to reduce to US$439.8 mn by 2024. In the coming years, the market will have to experience a patent cliff as the top U.S. brands of bacterial conjunctivitis drugs, such as…
Bacterial Conjunctivitis Drugs Market Driven by Rising Incidence of Ophthalmic B …
The U.S. market for bacterial conjunctivitis drugs is extremely fragmented, leading to commensurate competition among players. The entry barriers faced by new players despite having good research and development capabilities, is lack of capital, Transparency Market Research (TMR) states in its new report on the U.S. market for bacterial conjunctivitis drugs. R&D involves huge costs and this limits the production. Mergers and acquisitions and other forms of strategic alliances can…
Bacterial Conjunctivitis Drugs Market Driven by Rising Incidence of Ophthalmic B …
The U.S. market for bacterial conjunctivitis drugs has been declining sharply over the last few years. Analysts project the trend to continue in the coming years. In 2013, the market’s opportunity was valued at US$473.3 mn, which is likely to reduce to US$439.8 mn by 2024. In the coming years, the market will have to experience a patent cliff as the top U.S. brands of bacterial conjunctivitis drugs, such as…
